S. D. Muga

PI3K signaling pathway is activated by PIK3CA mRNA overexpression and copy gain in prostate tumors, but PIK3CA, BRAF, KRAS and AKT1 mutations are infrequent events

S. Serrano, J. Lloreta, M. Salido, 2011, Modern Pathology.

ERG overexpression plus SLC45A3 (prostein) and PTEN expression loss: Strong association of the triple hit phenotype with an aggressive pathway of prostate cancer progression

L. Serrano, Alba Font-Tello, N. Juanpere, 2017, Oncotarget.

Molecular alterations of EGFR and PTEN in prostate cancer: association with high-grade and advanced-stage carcinomas

S. Serrano, J. Lloreta, M. Salido, 2010, Modern Pathology.

KLF6 and TP53 mutations are a rare event in prostate cancer: distinguishing between Taq polymerase artifacts and true mutations

S. Serrano, J. Lloreta, J. Lorente, 2008, Modern Pathology.

FGFR3 mutations in prostate cancer: association with low-grade tumors

S. Serrano, J. Lloreta, S. Mojal, 2009, Modern Pathology.